|
|
|
|
LEADER |
03320nam a2200733Ia 4500 |
001 |
10.3389-fnhum.2021.721029 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 16625161 (ISSN)
|
245 |
1 |
0 |
|a Neurocognitive Disorder and Emotional Symptoms in HIV+ Brazilian Elderly: Influence of Gender, Income, Diet, and Sleep
|
260 |
|
0 |
|b Frontiers Media S.A.
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3389/fnhum.2021.721029
|
520 |
3 |
|
|a The purpose of this study was to identify factors associated with HIV-associated neurocognitive disorder (HAND) and symptoms of anxiety and depression in HIV+ Brazilian elderly on antiretroviral treatments. The study included 112 HIV+ elderly who completed a questionnaire, tests for cognitive screening, attention, problem solving, processing speed, visual perception, memory, and anxiety and depression scales. The results showed presence of HAND (89.3%), pathological anxiety (48.2%) and depression (58%) in the sample. Higher income was a protective factor for HAND (OR = 0.33). Waking up well-rested (OR = 0.63) and better diet quality (OR = 0.62) reduced the chance of pathological anxiety. Higher education (OR = 0.74) and waking up well-rested (OR = 0.61) reduced the chance of depression. Being female (OR = 7.73) increased the chance of depression. It can be concluded that it is important to evaluate cognitive and emotional aspects of HIV+ elders and to consider social and educational status, diet, and sleep in interventions, paying special attention to elderly women. © Copyright © 2021 Barroso and Sousa.
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a aged
|
650 |
0 |
4 |
|a antiretroviral treatment (ART)
|
650 |
0 |
4 |
|a antiretrovirus agent
|
650 |
0 |
4 |
|a anxiety
|
650 |
0 |
4 |
|a anxiety assessment
|
650 |
0 |
4 |
|a anxiety disorder
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a attention test
|
650 |
0 |
4 |
|a Brazilian
|
650 |
0 |
4 |
|a cognitive deficits
|
650 |
0 |
4 |
|a cognitive function test
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a depression
|
650 |
0 |
4 |
|a depression
|
650 |
0 |
4 |
|a dietary intake
|
650 |
0 |
4 |
|a disease association
|
650 |
0 |
4 |
|a educational status
|
650 |
0 |
4 |
|a elderly
|
650 |
0 |
4 |
|a elderly care
|
650 |
0 |
4 |
|a emotional disorder
|
650 |
0 |
4 |
|a female
|
650 |
0 |
4 |
|a Geriatric Anxiety Scale
|
650 |
0 |
4 |
|a Geriatric Depression Scale
|
650 |
0 |
4 |
|a geriatric patient
|
650 |
0 |
4 |
|a health survey
|
650 |
0 |
4 |
|a highest income group
|
650 |
0 |
4 |
|a HIV associated dementia
|
650 |
0 |
4 |
|a HIV-associated neurocognitive disorder (HAND)
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a human immunodeficiency virus (HIV)
|
650 |
0 |
4 |
|a Human immunodeficiency virus infected patient
|
650 |
0 |
4 |
|a Human immunodeficiency virus infection
|
650 |
0 |
4 |
|a income group
|
650 |
0 |
4 |
|a major clinical study
|
650 |
0 |
4 |
|a male
|
650 |
0 |
4 |
|a neuropsychological test
|
650 |
0 |
4 |
|a nutritional value
|
650 |
0 |
4 |
|a problem solving
|
650 |
0 |
4 |
|a processing speed
|
650 |
0 |
4 |
|a protection
|
650 |
0 |
4 |
|a risk factor
|
650 |
0 |
4 |
|a risk reduction
|
650 |
0 |
4 |
|a sex difference
|
650 |
0 |
4 |
|a sleep quality
|
650 |
0 |
4 |
|a sleep time
|
650 |
0 |
4 |
|a sleep waking cycle
|
650 |
0 |
4 |
|a social status
|
650 |
0 |
4 |
|a vision test
|
700 |
1 |
|
|a Barroso, S.M.
|e author
|
700 |
1 |
|
|a Sousa, K.C.R.
|e author
|
773 |
|
|
|t Frontiers in Human Neuroscience
|